Richard Frank
0
By RICHARD FRANK Demand for GLP-1 medications soared last year and shows no signs of stopping in 2024. Employers and health plans are understandably ...
By RICHARD FRANK Demand for GLP-1 medications soared last year and shows no signs of stopping in 2024. Employers and health plans are understandably ...